Skip to main content

Controversies and Future Directions of Ocular Biomarkers in Alzheimer Disease.

Publication ,  Journal Article
Ong, SS; Doraiswamy, PM; Lad, EM
Published in: JAMA Neurol
June 1, 2018

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JAMA Neurol

DOI

EISSN

2168-6157

Publication Date

June 1, 2018

Volume

75

Issue

6

Start / End Page

650 / 651

Location

United States

Related Subject Headings

  • Retina
  • Optic Nerve
  • Humans
  • Forecasting
  • Biomarkers
  • Alzheimer Disease
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ong, S. S., Doraiswamy, P. M., & Lad, E. M. (2018). Controversies and Future Directions of Ocular Biomarkers in Alzheimer Disease. JAMA Neurol, 75(6), 650–651. https://doi.org/10.1001/jamaneurol.2018.0602
Ong, Sally S., P Murali Doraiswamy, and Eleonora M. Lad. “Controversies and Future Directions of Ocular Biomarkers in Alzheimer Disease.JAMA Neurol 75, no. 6 (June 1, 2018): 650–51. https://doi.org/10.1001/jamaneurol.2018.0602.
Ong SS, Doraiswamy PM, Lad EM. Controversies and Future Directions of Ocular Biomarkers in Alzheimer Disease. JAMA Neurol. 2018 Jun 1;75(6):650–1.
Ong, Sally S., et al. “Controversies and Future Directions of Ocular Biomarkers in Alzheimer Disease.JAMA Neurol, vol. 75, no. 6, June 2018, pp. 650–51. Pubmed, doi:10.1001/jamaneurol.2018.0602.
Ong SS, Doraiswamy PM, Lad EM. Controversies and Future Directions of Ocular Biomarkers in Alzheimer Disease. JAMA Neurol. 2018 Jun 1;75(6):650–651.

Published In

JAMA Neurol

DOI

EISSN

2168-6157

Publication Date

June 1, 2018

Volume

75

Issue

6

Start / End Page

650 / 651

Location

United States

Related Subject Headings

  • Retina
  • Optic Nerve
  • Humans
  • Forecasting
  • Biomarkers
  • Alzheimer Disease